BLOOMINGTON, Ind. – Innovation needs investment, particularly in the early stages of development for many of Indiana’s life sciences companies. A conference being presented Feb. 21 in Indianapolis by the Indiana University Kelley School of Business will offer practical guidance on funding strategies and finding support from government, private equity firms and venture funds…. Read more »
Center for the Business of Life Sciences
Kelley School conference goes to Indiana’s “frontlines of treating cancer”
INDIANAPOLIS – More than 1.7 million people are diagnosed with cancer and about 610,000 people die from the disease annually, according to the National Cancer Institute. Researchers at Indiana universities and life sciences companies are part of the fight to effectively treat cancer and hopefully find a cure for it in the future. The… Read more »
Kelley conference to examine the role of foods we eat as part of Indiana’s life sciences industry
BLOOMINGTON, Ind. – Many may remember their parents’ admonition to “eat your vegetables.” Healthcare providers warn against taking in too many calories, too much sugar and too much fat. Some doctors are writing prescriptions for healthier foods. On the menu for the next event in the Indiana Life Sciences Collaboration Conference Series is a… Read more »
Kelley School conference examines healthcare industry’s role in fighting the opioid epidemic
BLOOMINGTON, Ind. – Dr. Jennifer Walthall, secretary of the Indiana Family & Social Services Administration, will keynote “The Healthcare Industry in Pain Management and Addressing the Opioid Crisis,” a conference being presented Feb. 15 by the Indiana University Kelley School of Business. Walthall will kick off the conference, the latest event in the Indiana… Read more »
Kelley conference examines how disruption can benefit innovation
In his 2009 best-selling book, “The Innovator’s Prescription,” Harvard University scholar Clayton Christensen explained why many companies miss out on new waves of innovation. Successful companies with established products will get pushed aside unless managers know how and when to abandon traditional business practices, he said. Life sciences companies were among those analyzed in the… Read more »